CastleKnight Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-183,400
Closed -$1.19M 436
2025
Q1
$1.19M Buy
183,400
+85,100
+87% +$611K 0.05% 205
2024
Q4
$792K Sell
98,300
-77,400
-44% -$638K 0.02% 266
2024
Q3
$1.43M Buy
+175,700
New +$1.16M 0.06% 179
2024
Q2
Sell
-42,600
Closed -$452K 362
2024
Q1
$452K Hold
42,600
0.03% 268
2023
Q4
$342K Hold
42,600
0.02% 261
2023
Q3
$350K Hold
42,600
0.02% 260
2023
Q2
$341K Sell
42,600
-9,500
-18% -$70K 0.04% 236
2023
Q1
$422K Hold
52,100
0.04% 195
2022
Q4
$327K Sell
52,100
-17,000
-25% -$119K 0.04% 162
2022
Q3
$476K Sell
69,100
-69,100
-50% -$480K 0.07% 146
2022
Q2
$1.16M Hold
138,200
0.19% 88
2022
Q1
$3.16M Sell
138,200
-60,600
-30% -$1.48M 0.45% 36
2021
Q4
$5.49M Buy
+198,800
New +$5.32M 1.13% 12

Other funds holding BHC

CastleKnight Management's BHC Position: Q2 2025 in Review

CastleKnight Management sold out of Bausch Health (BHC) in Q2 2025, closing a stake of 183,400 shares — an estimated $1.19M sold.

CastleKnight Management first reported a position in BHC in Q4 2021 and held it in 13 quarters. The position peaked at $5.49M in Q4 2021. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2025.

  • CastleKnight Management reported no remaining Bausch Health position as of Q2 2025 after selling out during the quarter.
  • CastleKnight Management sold 183,400 Bausch Health shares in Q2 2025, an estimated $1.19M.
  • CastleKnight Management first reported a position in Bausch Health in Q4 2021 and held it in 13 quarters.
  • CastleKnight Management's Bausch Health position peaked at $5.49M in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2025.

Based on CastleKnight Management's 13F filing for Q2 2025, filed 14 Aug 2025.